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S U M M A R Y
Objective: Helicobacter pylori has been associated with hyperemesis gravidarum in some geographical
regions. The prevalence of H. pylori in Arab Israeli women in the Upper Galilee and its association with
hyperemesis gravidarum has not been studied previously. We aimed to examine if hyperemesis
gravidarum is associated with H. pylori in this population.
Methods: Subjects with hyperemesis gravidarum carrying a singleton fetus were recruited prospec-
tively. Women with an uncomplicated pregnancy served as controls. All patients underwent 13C-urea
breath testing to assess for H. pylori infection.
Results: A total of 72 subjects, including 24 patients with hyperemesis gravidarum and 48 controls, aged
28.8  5.3 years, were included. H. pylori infection was identiﬁed in 75.0% (18/24) of cases and 60.4% (29/48)
of controls (p = not signiﬁcant). H. pylori infection did not correlate with age, fetal sex, or the number of
previous pregnancies (p = not signiﬁcant).
Conclusion: H. pylori does not seem to increase the likelihood of hyperemesis gravidarum in Arab Israeli
women. However, given the high background prevalence of H. pylori in this population, a larger study is
required to corroborate these ﬁndings. (MOH20110066)
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Nausea and vomiting may complicate up to 70% of pregnancies,
however the prevalence of hyperemesis gravidarum (HG),
characterized by weight loss, nutritional deﬁciency, ketonuria,
and ﬂuid and electrolyte instability, is rare (0.2–0.3%).1–6 The
physiological basis for HG is incompletely understood. Neverthe-
less, several risk factors have been identiﬁed, including a personal
or family history of HG, a female fetus or multiple gestation,
gestational trophoblastic disease, fetal trisomy 21, hydrops fetalis,
and maternal Helicobacter pylori infection.7 Some of these risk* Corresponding author at: 39 Jabotinsky St., Petah Tikva, ISRAEL 49100.
Tel.: +972-3-9377236; fax: +972-3-9210313.
E-mail address: dboltin@gmail.com (D. Boltin).
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1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).factors suggest that pregnancy growth hormones (human chorionic
gonadotropin (hCG), estradiol, progesterone) may be responsible
for HG.8 However, a possible association with H. pylori implies
additional immune-mediated factors.6,7,9–11
H. pylori is a Gram-negative, spiral-shaped, ﬂagellated organism
uniquely adapted to colonize the gastric mucous layer. The
bacterium is generally acquired during early childhood and may
lead to superﬁcial gastritis, peptic ulcer disease, and rarely MALT
lymphoma or adenocarcinoma.12 Epidemiological studies are
inconsistent regarding an association between HG and H.
pylori. The positive identiﬁcation of H. pylori in this setting relies
greatly on the modality of testing, the deﬁnition of HG, and the
background prevalence of H. pylori in the studied population.
The prevalence of H. pylori in subjects with HG has never been
studied in the Eastern Mediterranean region.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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2.1. Patients
Between January 1, 2011 and December 31, 2013, consecutive
pregnant women presenting to the general obstetrics outpatient
clinic at St Vincent French Hospital, Nazareth, were screened for
eligibility. Subjects between 6 and 14 weeks of gestation with a
diagnosis of HG were enrolled prospectively. HG was deﬁned by
the presence of all of the following criteria: (1) intractable nausea
and vomiting occurring at least three times per day; (2) 80 mg/dl
ketonuria on urinary dipstick; (3) weight loss of at least 5% of body
weight since the onset of symptoms. All eligible subjects had
conﬁrmation of a viable, singleton pregnancy using ultrasound
examination. The following patients were excluded: known
thyroid disease, diabetes mellitus, current or previous gestational
diabetes, multiple gestation, fetal malformation, chromosomal
abnormality, gestational trophoblastic disease, psychiatric disease
requiring ongoing follow-up, gastrointestinal disease requiring
ongoing follow-up, previous upper gastrointestinal surgery,
previous testing for or treatment of H. pylori.
For every patient with HG, two controls were recruited,
matched for age, gestational age, gravidity, and parity. The study
ﬂowchart (CONSORT) is shown in Figure 1. The study was
performed in accordance with the principles of the Declaration
of Helsinki and Good Clinical Practice (GCP) and was approved by
the Human Subjects Protection Program of St Vincent French
Hospital, Nazareth. All patients provided written informed consent
prior to recruitment.
2.2. Clinical assessment
Prior to enrollment, patients underwent a personal interview
and physical examination by the study physician (SA) in order to
conﬁrm the presence of HG according to the stated clinical and
laboratory criteria.
2.3. 13C-urea breath test
All patients underwent a 13C-urea breath test performed
according to European guidelines.13 Proton pump inhibitors wereFigure 1. CONSORT ﬂowchart. (Abbreviations: HG, hywithheld for at least 7 days beforehand. The test was performed
using a continuous real-time methodology (BreathID; Exalenz Ltd,
Jerusalem, Israel). All patients received 75 mg of 13C-urea with a
4.0 g citric acid-based powder (Citrica, Rafa Laboratories, Israel).
Based on molecular correlation spectrometry, the BreathID
continuously measured 13CO2 and
12CO2 concentrations from
the patient’s breath and established the 13CO2/
12CO2 ratio, which
was displayed versus time on the screen. Results were obtained
within 6–20 min and printed on a thermal printer.
2.4. Follow-up
Patients were contacted by telephone at 15–17 weeks of
gestation and again 2 weeks following the estimated date of
delivery. Patients were questioned regarding symptom resolution,
pregnancy outcome, and H. pylori treatment.
2.5. Statistical analysis
Data analysis was carried out using IBM SPSS Statistics for
Windows, version 21.0 (IBM Corp., Armonk, NY, USA). We
determined that 23 patients with HG and 40 controls were
needed in order to detect a 30% difference in H. pylori 13C-urea
breath test positivity with 80% power and a = 0.05. This
calculation was made assuming a background H. pylori seroposi-
tivity of 40%.14,15 In order to allow for withdrawal of consent
and exclusion of cases, a further 10 patients with HG were
deemed necessary. Therefore, we aimed to enroll 30 subjects
with HG (Figure 1).
Continuous variables such as age were reported as the
mean  standard deviation or median (range), as appropriate. The
normality of distribution of continuous variables was assessed using
the Kolmogorov–Smirnov test (cut-off at p = 0.01). Categorical
variables were described using frequency distributions and were
presented as the frequency (n (%)). Depending on the distribution,
continuous variables were compared across groups using one-way
analysis of variance (ANOVA) or the Kruskal–Wallis test. Pair-wise
post-hoc comparisons for signiﬁcance across differences were
assessed by Bonferroni test or the Mann–Whitney U-test. Categorical
variables were compared across groups using the Chi-square test
(exact as necessary). The Pearson correlation coefﬁcient was used toperemesis gravidarum; Hp, Helicobacter pylori.).
Table 1
Patient characteristics
Hyperemesis gravidarum Controls p-Value
N (%) 24 (100) 48 (100) -
Maternal age, years, mean (SD) 27.0 (5.9) 29.7 (4.7) <0.01
Gestationa, weeks, mean (SD) 9.4 (1.5) 9.2 (1.3) 0.60
Gravida, n (%) 1.8 (0.9) 3.1 (1.9) 0.04
Male fetus, n (%) 14 (58) 18 (38) 0.13
Symptom resolution, weeks, mean (SD) 15.7 (4.1) - -
SD, standard deviation.
a Gestation at the time of screening.
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considered signiﬁcant at p < 0.05.
3. Results
3.1. Patient characteristics
Twenty-four patients with HG aged 27.0 (5.9) years and
48 pregnant controls aged 29.7 (4.7) years were included (t = 3.1,
p < 0.01) (Table 1). All subjects identiﬁed themselves ethnically as
Arab Israeli. At the time of screening, mean gestation was 9.4 (1.5)
weeks in the HG group and 9.2 (1.3) weeks in controls (t = 0.5,
p = 0.60). The mean number of pregnancies (including current) was
1.8 (0.9) in subjects with HG and 3.1 (1.9) in controls (t = 2.1,
p = 0.04). All pregnancies were singleton.
3.2. Follow-up
Fetal sex was male in 14 (58%) HG subjects and 18 (38%)
controls (p = 0.13). The mean gestation at the time of cessation of
vomiting was 15.7 (4.1) weeks in subjects with HG. All fetuses
were carried to term with the exception of one control subject who
experienced a spontaneous early second trimester abortion
(Figure 1).
3.3. H. pylori infection
The 13C-urea breath test was positive in 75.0% (18/24) of cases
and 60.4% (29/48) of controls (p = 0.30) (Table 2). Using logistic
regression analysis, H. pylori positivity was independent of
maternal age, gravidity, and fetal sex.
4. Discussion
Our ﬁndings do not support an association between HG and
H. pylori infection. Although we found that H. pylori infection was
more prevalent among subjects with HG compared to controls, this
difference did not reach statistical signiﬁcance. This is the ﬁrst
study emanating from the Eastern Mediterranean region to
examine H. pylori in subjects with HG.
Data in the existing medical literature are inconsistent
regarding a possible connection between HG and H. pylori
infection. For example, a meta-analysis of 25 case–control studies
included 14 studies that found an association between HG and
H. pylori and 11 studies that did not.16 These studies were highly
heterogeneous in their designs, their deﬁnitions of HG, and the
study population. Another signiﬁcant limitation is that H. pyloriTable 2
Helicobacter pylori positivity in patients with hyperemesis gravidarum
Hyperemesis gravidarum Controls p-Value
Helicobacter pylori-positive 18 (75.0) 29 (60.4) 0.30exposure was almost universally deﬁned by IgG antibody
positivity, which is not speciﬁc for current infection. In this
meta-analysis, exposure to H. pylori was associated with a 3.3-fold
increased risk of HG (95% conﬁdence interval 2.25–4.90).
Interestingly, in studies with a clear deﬁnition of HG (such as in
ours) the association was weaker. Furthermore, in studies
emanating from regions with a high background prevalence of
H. pylori, the association with HG was weaker. For example, Lee
et al. found a background H. pylori prevalence of 65% in Hispanic
American subjects with HG and 67% in those without HG (p = not
signiﬁcant).17 In Turkey, Karadeniz et al. found 68% and 79% H.
pylori positivity in subjects with and without HG, respectively
(p = not signiﬁcant).18 These negative studies are consistent with
our ﬁndings, where the prevalence of H. pylori in a demographic
subsection was unexpectedly found to be signiﬁcantly higher than
the general population and unrelated to HG.
In another study emerging from our geographical region, Shirin
et al. reported that subjects with ﬁrst trimester vomiting were
more likely to harbor H. pylori (81.2% vs. 65%, p = 0.004).19
However, this was a retrospective questionnaire-based study with
substantial recall bias, enquiring about vomiting rather than HG.
Furthermore, H. pylori was assessed by serology alone, and the
study did not include Arab Israeli women. Interestingly, smoking,
but not H. pylori, was associated with vomiting in the second
trimester.19
The H. pylori positivity rate of 74% in cases vs. 60% in controls
observed in our study would have reached statistical signiﬁcance
if 73 women with HG had been included (given a case-to-control
ratio of 1:2). Our power calculation that only 20 women with HG
were needed was based on a gross underestimation of the
background H. pylori prevalence in the Arab Israeli population.
According to the most recent data, H. pylori positivity among
Jewish Israelis is approximately 45% and in Arab Israelis 42%,
based on serology.20 However, despite declining rates among
Jewish adolescents, seropositivity among Arab adolescents in
Israel is increasing. Given that serology does not distinguish
between past and current infection, these ﬁgures are likely to be
an overestimation of the true prevalence. H. pylori positivity in a
given population is related to socioeconomic factors, such as
sanitation and crowding,21,22 as well as prior exposure to
antibiotics and proton pump inhibitors.23 Some of these factors
may account for the discrepancy between the previously
reported prevalence of H. pylori in Israel and the higher rate
observed in our study controls.
In studies that identify H. pylori infection as a risk factor for HG,
the physiological basis via which H. pylori gastritis leads to
vomiting is complex. H. pylori may alter neurocrine, paracrine, and
endocrine pathways and lead to gastrointestinal symptoms even in
the absence of endoscopic mucosal disease. In fact, the severity of
symptoms could be directly related to the degree of microscopic
inﬂammation and the density of H. pylori.24 An alternative
mechanism for hyperemesis could be H. pylori-induced delayed
gastric emptying (gastroparesis).25,26 Further support for an
infectious etiology for HG comes from reports of symptom
D. Boltin et al. / International Journal of Infectious Diseases 29 (2014) 292–295 295regression following antibiotic treatment.27 Moreover, pregnant
women might have a higher risk of H. pylori infection compared to
their non-pregnant counterparts. Gastric acid secretion is de-
creased in early pregnancy due to metabolic and endocrine factors.
This, coupled with altered immune function in pregnancy, could
predispose to H. pylori infection.10 Lanciers et al. have shown that
H. pylori IgM is more common in pregnant subjects compared to
matched controls, suggesting that de novo infection with H. pylori
occurs in early pregnancy.28 Activation of quiescent disease might
also occur in early pregnancy, as suggested by in vitro studies that
have shown H. pylori-associated gastritis to be exacerbated by
estradiol.29 Etiologies other than H. pylori that have been suggested
for HG include pregnancy hormones (hCG, estradiol, progester-
one), hyperthyroidism, genetic incompatibility, nutritional deﬁ-
ciencies, immunological factors, and psychological factors.30,31
Clearly, no single factor can account for HG in all cases.
We found that patients with HG were more likely to be younger
and to have had fewer previous pregnancies than matched
controls. Although these factors have not been associated
consistently with HG in the past, they are likely a reﬂection of
the fact that subjects with HG are unlikely to attempt another
pregnancy, as the risk of recurrence may reach 19%.32
The strength of this study lies in its prospective, controlled
design, the stringent inclusion criteria employed, and the use of the
13C-urea breath test. The 13C-urea breath test has a diagnostic
accuracy comparable to endoscopic tests such as histology, culture,
or rapid urease testing.33 It is noteworthy that none of the studies
included in the recent meta-analysis utilized 13C-urea breath tests
or endoscopic tests, but rather relied on serology.16 Serology is not
speciﬁc for current infection and is further limited by cross-
reactivity, inter-observer variability, and a lack of validity in
subjects over the age of 45 years and in certain ethnic groups. For
this reason the positive predictive value, negative predictive value,
and accuracy of H. pylori IgG serology are 46%, 61%, and 52%,
respectively, compared to 92%, 90%, and 82%, respectively, for the
13C-urea breath test.34
Our study is limited by the sample size, which may not be large
enough given the high background prevalence of H. pylori in the
Arab Israeli population. Another limitation is the lack of control for
confounding and lack of a validated symptom score or clinical
endpoint such as the Rhodes index questionnaire, which could
potentially correlate H. pylori positivity with disease severity.
In conclusion, our ﬁndings do not support a connection
between HG and H. pylori in Arab Israelis; however this could
be due to the unexpectedly high prevalence of the organism. Larger
studies incorporating antibiotic treatment and clinical endpoints
in this population are warranted.
Conﬂict of interest: The authors have no funding or conﬂicts of
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